LOR 253(916151-99-0)
- Name: LOR 253
- Synonyms:LOR 253;
- Molecular Formula:C22H14FN5
- Molecular Weight:367.385
- CAS Registry Number:916151-99-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.916151-99-0 LOR-253 manufacturer/supplier
Assay:99% Appearance:white or off-white powder Package:aluminum oil bag Storage:0~20鈩?nbsp;Transportation:by express,by sea, by air Application:LOR-253 CAS:916151-99-0 is used as API medicine
Min. Order:1Gram
Supplier:Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd [
China (Mainland)] CAS No.916151-99-0 LOR 253
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:LOR 253
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.916151-99-0 APTO-253
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.916151-99-0 LOR 253
Assay:99% Appearance:white powder Package:5mg Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Shanghai Yuanye Bio-Technology Co., Ltd. [
China (Mainland)] CAS No.916151-99-0 LOR-253
Assay:>98% Appearance:Solid powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:LOR-253 is a novel small molecule with potent anti-tumor activity in cancer cells via induction of the gene that expresses the Kr眉ppel-like factor 4 (KLF4) master transcription factor, leading to...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1177489-18-7/CASPASE-13 INHIBITOR I
- 1142214-62-7/AM-1638
- 4727-31-5/Kartogenin
- 195883-07-9/YM 273
- 865784-01-6/ON 013105
- 857070-65-6/1-((3-hydroxy-6-Methylpyridin-2-yl)Methyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazole-6-carbaldehyde
- 857067-38-0/2-((6-(hydroxyMethyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazol-1-yl)Methyl)-6-Methylpyridin-3-ol
- 245414-50-0/3-(((2R,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbaMoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-yl)carbaMoyl)-2-Methylphenyl acetate
- 857071-75-1/(E)-3-(4-Methyl-2-nitrophenyl)prop-2-en-1-ol
- 662151-10-2/ML-220
- 1354792-97-4/NI-07
- 1005780-62-0/TAK-593
- 926291-77-2/Benzeneethanol, β-aMino-3-chloro-, (βR)-
- 1286739-19-2/6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one
- 131918-62-2/19-nor-Doxercalciferol
- 1260907-17-2/GSK 525762A
- 333352-59-3/NBD-557
- 1096708-71-2/6-Amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-4-pyrimidinecarboxamide
- 914462-92-3/Rolapitant hydrochloride
- 916151-99-0/LOR 253
- 929721-98-2/Impurity A of Maxacalcitol
- 1217835-38-5/(R)-(2,3-dimethyl-3-((trimethylsilyl)oxy)butyl)diphenylphosphine oxide
- 87407-51-0/(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((S)-5-((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)propan-1-ol
- 112875-61-3/(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol
- 333353-44-9/NBD-556
- 81506-24-3/(Z)-2-((3S,5R)-3,5-bis((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethanol
- 1431612-23-5/UNC 1999
- 884488-07-7/(1S,3aR,7aR)-1-((S)-1-(3-hydroxy-3-Methylbutoxy)ethyl)-7a-Methylhexahydro-1H-inden-4(2H)-one
- 70550-73-1/(1R,3aR,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one
- 215509-33-4/(2S)-2-((1R,3aR,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol